More Business Wire
View Older Stories View Newer Stories-
Anetac Launches Expert Community Program to Address Critical Gaps in Non-human and Human Identity Vulnerability and Security
-
Guidewire Software, Inc. Announces Proposed Convertible Senior Notes Offering
-
Tolerance Bio, Inc. Launches With $17.2 Million in Seed Financing to Advance Thymus-Based Therapies for Immune-Mediated Diseases
-
Innoviva Specialty Therapeutics to Present New Clinical Data From Its Development Pipeline and Broad Commercial Portfolio at IDWeek 2024
-
Vivo Infusion Welcomes Stephan Rodgers as CEO, Positioning Vivo for Continued Market Leadership
-
Dollar General Unwraps Holiday Cheer With Added Savings on Toys
-
Xylem Appoints Meredith Emmerich to Lead Applied Water Segment
-
Ryder Authorizes New Share Repurchase Program
-
MultiBank Group Awarded 'Best FX Institutional Liquidity Provider' at Forex Expo Dubai 2024
-
Tim Buckley Elected to Pfizer’s Board of Directors
-
Teledyne FLIR Defense Unveils Cerberus XL C-UAS Mobile Counter-Drone System at AUSA 2024
-
Karooooo Increases Earnings by 31% Driven by Strong Subscription Revenue Growth and Higher Gross Margins
-
Sila Realty Trust, Inc. Provides Update After Hurricanes
-
Eaton Introduces Aftermarket Endurant Automated Manual Transmission Clutch and Flywheel Kits
-
DirectEmployers Launches OFCCP Compliance Essentials, A VEVRAA & Diversity Job Listing Solution for Small Employers
-
Metals Acquisition Limited Provides Notice of Release of Third Quarter 2024 Results and Conference Call Details
-
Arizona Sonoran Initiates Pre-Feasibility Study; Appoints M3 Engineering and Begins PFS Workstreams
-
Sage Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024
-
Mobileye Announces Timing of its Third Quarter 2024 Results
-
NGL Energy Partners Announces Earnings Call
-
Perfect Corp. to Announce Financial Results for Third Quarter of 2024 on October 29, 2024
-
Radian to Webcast Third Quarter Conference Call
-
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024
-
Antiverse Raises £3.5M ($4.6M) to Advance Generative AI Antibody Design Platform
-
Johnson & Johnson Reports Q3 2024 Results
-
FB Financial Corporation Reports Third Quarter 2024 Financial Results
-
Kioxia Demonstrates Flexible Data Placement-Enabled SSD Running RocksDB at 2024 OCP Global Summit
-
ANANDA Scientific Announces a Clinical Trial Evaluating Nantheia™ ATL5, in the treatment of Co-Occurring Opioid Use Disorder and Chronic Pain
-
Spirit Electronics Offers TE Connectivity’s Sensor Products in Franchised Distribution Agreement
-
Alleo and Ubiquigent Enter AI-driven Strategic Partnership to Accelerate DUB-focused Drug Discovery
-
Avicena Appoints Former Oclaro CEO Greg Dougherty to its Board of Directors
-
Mercer CFA Institute Global Pension Index 2024 Highlights Need for Retirement System Improvements Given Falling Birth Rates and Increasing Longevity
-
CareDx Reports Preliminary Financial Results for Third Quarter 2024
-
Oculi Launches Early Access Evaluation Program with Magenta and Burgundy Platforms
-
Secure Code Warrior Research: Critical Infrastructure Industries Making Progress on Secure-by-Design Developer Readiness
-
Newmont and MKS PAMP Partner to Launch Mine-to-Market Traceable Gold Bar at the Largest U.S. Wholesaler
-
Valeo Increases Truck Loading/Unloading Speed 6x with Slip Robotics
-
Snapdocs Expands Digital Closing Platform and Unveils New Brand Identity
-
Excelsior Energy Capital and Proximal Energy Enter Multiyear Agreement for AI-Powered Asset Management
-
KRISPY KREME® Celebrates Biggest Supermoon of 2024 with New Supermoon Super Doughnut, Available Only Oct. 17
-
Core4ce Acquires Azimuth Corporation to Strengthen Defense and Intelligence Community Operations
-
unWired Broadband Announces Appointment of Matt Murphy as Chief Executive Officer
-
Sound Growth Partners Invests in Stueve
-
UnitedHealth Group Reports Third Quarter 2024 Results
-
Alipay+ Launches on KHQR, Facilitating Cross-border Mobile Payments Into Cambodia
-
Neurosurgeon Joseph Georges, P.I. for Diakonos Oncology’s Phase 1 Trial of Its Unique Dendritic Cell Vaccine for Gliobastoma, Receives the CNS 2024 Rosenblum-Mahaley Clinical Research Award
-
Airway Therapeutics to Launch a Multinational Phase 3 Trial of Zelpultide Alfa for Preterm Neonates at Risk of Bronchopulmonary Dysplasia
-
Toyoda Gosei Starts Operations at Airbag Plant in Northern India
-
Wolfspeed Announces $750M in Proposed Funding from U.S. CHIPS Act and Additional $750M From Investment Group Led By Apollo, Galvanizing Global Leadership in Delivering Next-Generation Silicon Carbide
-
DISCO Officially Launches its Cecilia AI Platform in Europe
